publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
articl
graphic
abstract
highlight
pacman
crisprbas
strategi
rnaguid
viral
rna
inhibit
degrad
pacmac
effect
target
cleav
sequenc
pacmac
reduc
iav
load
respiratori
epitheli
cell
group
six
crrna
target
coronavirus
summari
coronaviru
diseas
pandem
caus
viru
highlight
need
antivir
approach
target
emerg
virus
effect
vaccin
pharmaceut
demonstr
strategi
pacman
prophylact
antivir
crispr
human
cell
viral
inhibit
effect
degrad
rna
sequenc
live
influenza
viru
iav
human
lung
epitheli
cell
design
screen
crispr
rna
crrna
target
conserv
viral
region
identifi
function
crrna
target
approach
effect
reduc
iav
load
respiratori
epitheli
cell
bioinformat
analysi
show
group
six
crrna
target
coronavirus
develop
safe
effect
system
respiratori
tract
deliveri
pacman
potenti
becom
import
pancoronaviru
inhibit
strategi
world
current
face
pandem
novel
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
prevent
vaccin
proven
pharmacolog
treatment
predict
develop
safe
effect
vaccin
prevent
take
month
time
mani
million
peopl
may
infect
rapidli
grow
number
case
death
around
world
emerg
threat
requir
nimbl
target
mean
protect
coronavirus
caus
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
abl
spontan
transfer
human
divers
anim
host
act
viral
reservoir
press
need
develop
method
broadli
combat
coronavirus
may
emerg
futur
li
et
al
mohd
et
al
shi
hu
recent
report
show
two
strain
l
differ
genom
sequenc
circul
like
evolv
highlight
need
pancoronaviru
target
strategi
tang
et
al
novel
coronaviru
caus
belong
famili
positivesens
rna
virus
typic
infect
upper
lower
respiratori
tract
caus
diseas
direct
cytotox
effect
induct
host
cytokinemedi
inflamm
liu
et
al
life
cycl
like
similar
close
relat
coronaviru
caus
sar
viru
enter
cell
releas
rna
genom
cytoplasm
synthes
negativesens
genom
subgenom
rna
viral
mrna
new
copi
posit
sens
viral
genom
synthes
figur
du
et
al
liu
wherea
ongo
vaccin
trial
work
prime
human
immun
system
recogn
coronaviru
protein
attenu
virus
decreas
viral
entri
cell
rappuoli
altern
antivir
approach
propos
reli
crisprbas
system
recogn
degrad
intracellular
viral
genom
result
viral
mrna
figur
target
positivesens
genom
viral
mrna
simultan
degrad
viral
genom
templat
replic
viral
gene
express
would
expect
robustli
limit
viral
replic
inhibit
rna
virus
human
cell
use
class
type
vid
system
deriv
ruminococcu
flavefacien
recent
discov
rnaguid
rna
endonucleas
konermann
et
al
yan
et
al
employ
crisprassoci
rna
crrna
contain
customiz
spacer
sequenc
direct
protein
specif
rna
molecul
target
rna
degrad
high
catalyt
activ
human
cell
provid
potenti
mechan
target
specif
viral
rna
genom
degrad
viral
gene
express
inhibit
small
size
amino
acid
high
specif
strong
catalyt
activ
chose
rather
protein
target
destroy
rna
virus
includ
influenza
viru
iav
gootenberg
et
al
smargon
et
al
yan
et
al
first
studi
use
variant
target
viral
sequenc
human
cell
bawag
et
al
freij
et
al
remain
unknown
whether
crispr
tool
design
effect
target
cleav
sequenc
addit
approach
differ
previou
studi
aim
develop
strategi
simultan
target
multipl
speci
virus
within
famili
provid
broad
pancoronaviru
protect
work
develop
prophylact
antivir
crispr
human
cell
pacman
strategi
form
genet
intervent
target
iav
potenti
coronavirus
creat
bioinformat
pipelin
defin
highli
conserv
region
across
mani
sequenc
genom
target
region
use
viral
sequenc
degrad
time
manuscript
submiss
unabl
gain
access
live
strain
therefor
test
approach
use
synthes
fragment
b
hypothet
life
cycl
upon
entri
genom
rna
releas
posit
strand
rna
genom
serv
templat
make
neg
strand
genom
subgenom
templat
use
produc
copi
posit
strand
viral
genom
viral
mrna
b
inhibit
viral
function
replic
directli
target
cleav
viral
positivesens
rna
well
live
infect
use
iav
strain
human
lung
epitheli
cell
design
screen
panel
crrna
pool
target
conserv
viral
region
defin
effect
crrna
demonstr
abil
approach
cleav
fragment
reduc
amount
iav
infect
human
lung
epitheli
cell
bioinformat
analysi
reveal
group
six
crrna
target
sequenc
coronavirus
well
group
crrna
abl
target
sequenc
coronavirus
use
crrna
pool
target
differ
region
viru
differ
strain
coronaviru
system
could
possibl
buffer
viral
evolut
escap
well
use
protect
futur
relat
pathogen
virus
remain
hurdl
overcom
strategi
use
clinic
pacman
potenti
becom
new
antivir
strategi
creat
effect
specif
crrna
sequenc
target
cleav
first
perform
bioinformat
analysi
align
publish
genom
patient
sarscov
merscov
genom
singlestrand
rna
genom
nt
encod
put
function
open
read
frame
chan
et
al
shang
et
al
wu
et
al
analysi
found
region
high
conserv
strain
well
sarscov
merscov
genom
figur
two
highli
conserv
region
contain
rnadepend
rna
polymeras
rdrp
gene
polypeptid
region
maintain
prolifer
coronavirus
nucleocapsid
n
gene
end
genom
encod
capsid
protein
viral
packag
target
highli
conserv
region
gener
silico
collect
possibl
crrna
figur
exclud
crrna
either
predict
potenti
offtarget
bind
mismatch
human
transcriptom
polyt
ts
sequenc
may
prevent
crrna
express
obtain
collect
crrna
tabl
wessel
et
al
design
synthes
crrna
crrna
target
conserv
sequenc
rdrp
n
gene
tabl
rational
target
two
region
significantli
reduc
viral
genom
subgenom
rna
mrna
templat
express
essenti
viral
protein
also
want
creat
robust
set
crrna
guard
loss
target
activ
mutat
escap
evalu
whether
effect
target
sequenc
creat
two
report
express
synthes
fragment
fuse
gfp
figur
tabl
appear
mainli
infect
respiratori
tract
cell
patient
liu
et
al
chose
use
human
lung
epitheli
cell
model
cell
line
creat
stabl
cell
line
express
lentivir
infect
follow
sort
mcherri
marker
coexpress
figur
first
investig
region
fragment
suscept
target
cleavag
transfect
transduc
report
cell
transduc
pool
four
crrna
target
either
rdrp
n
gene
region
figur
see
star
method
chose
evalu
effect
system
use
pool
crrna
context
live
viral
infect
would
limit
possibl
escap
due
mutat
singl
crrna
target
site
total
ten
group
test
crrna
tabl
twentyfour
hour
report
transfect
perform
flow
cytometri
examin
level
gfp
protein
express
collect
rna
cell
perform
quantit
realtim
pcr
examin
mrna
transcript
abund
observ
rdrptarget
crrna
pool
abl
repress
report
express
extent
compar
control
one
pool
target
central
region
rdrp
fragment
genom
coordin
particularli
effect
abl
repress
gfp
p
figur
tabl
one
pool
n
genetarget
crrna
genom
coordin
abl
substanti
repress
gfp
caus
decreas
express
p
figur
tabl
quantit
realtim
pcr
analysi
show
consist
result
rna
level
inhibit
respect
report
mrna
abund
p
p
tabl
variat
abil
differ
crrna
pool
repress
report
like
due
rna
secondari
structur
inher
genom
fragment
differ
bind
affin
crrna
sequenc
composit
next
independ
valid
perform
adjac
crrna
pool
introduc
via
lentivir
transduct
argu
approach
lentivirusderiv
rna
serv
pacman
target
prior
lentiviru
integr
dna
mimic
crrna
target
condit
would
appli
natur
infect
test
select
crrna
pool
includ
three
best
group
one
less
effici
group
lentivir
moi
result
reveal
similar
pattern
transfect
experi
best
group
abl
repress
report
measur
flow
cytometri
figur
rna
abund
measur
quantit
realtim
pcr
figur
valid
effect
repress
report
cotransfect
report
pool
crrna
tile
along
whole
fragment
compar
pool
nontarget
control
crrna
tabl
found
rdrpor
ntarget
crrna
abl
repress
correspond
report
p
p
respect
figur
analysi
reveal
inhibit
sensit
crrna
concentr
sampl
lower
express
moder
decreas
inhibitori
activ
figur
thu
maintain
high
level
crrna
concentr
like
determin
factor
effect
tabl
design
crrna
sequenc
synthes
fragment
b
schemat
two
report
creat
synthes
viral
sequenc
contain
gfp
fuse
portion
rdrp
contain
gfp
fuse
portion
rdrp
n
c
schemat
construct
use
express
crrna
experi
workflow
challeng
lung
epitheli
cell
report
see
also
figur
tabl
sequenc
target
cleavag
notabl
viabil
differ
observ
cell
transfect
crrna
figur
data
togeth
suggest
pacman
effect
system
target
degrad
sequenc
human
cell
proper
design
crrna
import
obtain
highli
effici
inhibit
pacman
abl
inhibit
iav
infect
human
lung
epitheli
cell
access
live
viru
proofofconcept
elect
test
pacman
strategi
inhibit
strain
iav
rna
viru
similar
tropism
respiratori
tract
epitheli
cell
krammer
et
al
contrast
singl
continu
rna
genom
iav
genom
contain
eight
negativesens
rna
segment
play
import
role
packag
viral
rna
bud
virion
breen
et
al
zhou
et
al
previou
work
shown
iav
inhibit
use
mdck
cell
low
moi
target
somewhat
conserv
region
base
allel
frequenc
per
crrna
freij
et
al
contrast
work
chose
focu
target
highli
conserv
packag
region
across
eight
iav
segment
creat
crrna
target
broad
rang
iav
strain
align
complet
iav
genom
retriev
influenza
research
databas
search
conserv
region
analysi
work
other
show
segment
end
import
viral
packag
highli
conserv
eight
segment
breen
et
al
desselberg
et
al
dijk
et
al
muramoto
et
al
skehel
hay
zhou
et
al
due
conserv
natur
segment
end
target
could
potenti
inhibit
broad
rang
iav
strain
addit
previou
work
shown
interf
packag
one
segment
decreas
packag
effici
segment
thu
overal
virion
packag
fujii
et
al
gerber
et
al
lakdawala
et
al
muramoto
et
al
william
et
al
use
sequenc
represent
differ
strain
influenza
design
crrna
could
robustli
target
mani
differ
iav
strain
possibl
bioinformat
analysi
result
six
crrna
target
highli
conserv
genom
region
eight
iav
segment
total
crrna
tabl
test
effici
iavtarget
crrna
perform
screen
crrna
pool
stabl
cell
line
determin
effect
inhibit
iav
infect
figur
transfect
pool
six
crrna
target
given
iav
genom
segment
two
day
crrna
transfect
cell
challeng
strain
iav
apuerto
engin
express
mneongreen
gene
fluoresc
report
protein
hereaft
refer
moi
heaton
et
al
shaner
et
al
approxim
h
postchalleng
cell
analyz
iav
infect
flow
cytometri
microscopi
examin
percentag
cell
mneon
posit
segmenttarget
crrna
pool
calcul
foldchang
compar
cell
transfect
pool
nontarget
crrna
notabl
studi
use
high
moi
compar
previou
work
use
moi
bawag
et
al
freij
et
al
high
moi
requir
get
appropri
dynam
rang
detect
inhibit
iav
flow
cytometri
allow
evalu
crrna
robust
stringent
hightit
infect
condit
crrna
crrna
pool
target
segment
encod
neuraminidas
na
protein
deliv
consist
robust
result
across
differ
moi
reduct
moi
reduct
moi
figur
addit
crrna
pool
target
segment
encod
hemagglutinin
protein
also
show
moder
consist
inhibit
confirm
inhibitori
effect
lower
moi
saw
strong
inhibit
iav
target
respect
figur
possibl
trend
greater
inhibit
lower
viral
titer
suggest
pacman
could
effect
prevent
new
infect
typic
occur
exposur
low
level
viru
character
crrna
pool
perform
microscopi
quantif
mneon
cell
found
mneon
express
reduc
p
p
moi
respect
crrna
figur
trend
also
corrobor
flow
cytometri
figur
interestingli
mneon
report
sequenc
contain
iav
genom
suggest
abl
effect
rna
level
iav
segment
directli
target
togeth
data
show
pacman
abl
target
highli
conserv
viral
region
robustli
inhibit
viral
replic
human
lung
epitheli
cell
ask
exist
small
group
crrna
target
fulli
sequenc
iav
strain
analyz
strain
complet
segment
sequenc
identifi
possibl
crrna
refin
list
defin
smallest
number
crrna
could
target
mani
iav
genom
possibl
mismatch
analysi
reveal
group
crrna
could
cover
iav
minim
group
six
crrna
target
iav
genom
figur
tabl
one
valid
crrna
part
minim
pool
six
crrna
abl
target
iav
togeth
data
suggest
approach
potenti
paniavtarget
strategi
pleas
cite
articl
press
abbott
et
al
develop
crispr
antivir
strategi
combat
influenza
cell
http
past
two
decad
multipl
variant
coronaviru
includ
caus
sar
mer
emerg
anim
reservoir
infect
human
time
caus
signific
number
fatal
li
et
al
mohd
et
al
shi
hu
thu
design
strategi
could
broadli
target
prevent
viral
threat
includ
coronaviru
strain
current
resid
anim
would
invalu
resourc
ask
whether
possibl
design
minim
number
crrna
could
target
major
known
coronavirus
found
human
anim
contrast
previou
antivir
work
freij
et
al
focus
conserv
across
differ
strain
speci
viru
sought
target
mani
strain
possibl
minim
set
crrna
creat
even
broader
level
protect
given
famili
virus
analyz
known
coronaviru
genom
identifi
possibl
crrna
target
genom
end
approxim
million
possibl
crrna
figur
refin
list
identifi
smallest
number
crrna
could
target
known
coronaviru
genom
zero
mismatch
found
two
crrna
could
target
coronaviru
genom
includ
caus
sar
mer
six
crrna
abl
target
coronaviru
genom
crrna
cover
sequenc
coronavirus
mismatch
figur
tabl
abil
use
rel
small
number
crrna
broadli
target
see
also
figur
tabl
coronaviru
strain
highlight
uniqu
power
method
contrast
tradit
pharmaceut
vaccin
approach
resourc
provid
map
show
top
six
crrna
target
coronaviru
phylogenet
tree
figur
red
box
beta
coronavirus
genu
virus
caus
sar
mer
mainli
cover
three
crrna
crrna
genera
cover
crrna
addit
three
crrna
minim
set
six
crrna
includ
one
crrna
design
tabl
valid
part
pool
work
altogeth
target
known
human
coronavirus
broad
coverag
anim
coronavirus
recent
work
analyz
genom
indic
differ
subtyp
l
differ
viral
signatur
sequenc
tang
et
al
verifi
whether
target
l
strain
retriev
set
recent
sequenc
sequenc
global
initi
share
influenza
data
gisaid
notabl
target
genom
four
sequenc
carri
mismatch
figur
tabl
suggest
approach
robustli
target
differ
strain
emerg
power
antivir
system
abl
use
sequencespecif
crrna
protect
host
bacteri
cell
bacteriophag
infect
yan
et
al
pacman
strategi
repurpos
rnaguid
rna
endonucleas
activ
human
cell
viral
target
iav
demonstr
pleas
cite
articl
press
abbott
et
al
develop
crispr
antivir
strategi
combat
influenza
cell
http
system
effect
target
cleav
rna
sequenc
fragment
iav
properli
design
crrna
lung
epitheli
cell
addit
bioinformat
analys
suggest
minim
pool
six
crrna
abl
target
iav
strain
six
crrna
abl
target
sequenc
coronavirus
expand
applic
system
beyond
diagnost
sherlock
livecel
rna
imag
gootenberg
et
al
wang
et
al
yang
et
al
iav
found
highli
conserv
region
viral
genom
target
case
genom
region
encod
rdrp
nucleocapsid
protein
essenti
coronaviru
replic
function
chan
et
al
mcbride
et
al
rdrp
respons
catalyz
replic
viral
mrna
nucleocapsid
bind
genom
rna
protect
serv
one
two
main
structur
protein
virion
target
inhibit
protein
could
outsiz
effect
disabl
viru
product
function
addit
reduc
viral
load
degrad
viral
genom
target
iav
crrna
show
best
viral
inhibit
target
conserv
end
segment
encod
na
viral
surfac
protein
essenti
mediat
bud
new
virion
mcauley
et
al
prior
mutat
analysi
shown
mutat
packag
signal
one
segment
end
lead
decreas
packag
segment
indic
cooper
mechan
packag
iav
genom
muramoto
et
al
thu
inhibit
singl
iav
genom
segment
could
reduc
overal
packag
iav
synergist
fashion
import
note
pacman
current
proofofconcept
antivir
strategi
robustli
broadli
target
conserv
viral
sequenc
multipl
import
step
requir
test
clinic
trial
possibl
treat
one
immedi
next
step
valid
effici
specif
crrna
inhibit
infect
respiratori
tract
cell
live
viru
test
pacman
system
prophylact
system
introduc
viral
challeng
hypothes
pacman
could
also
use
reduc
viral
load
infect
also
import
examin
futur
test
crrna
select
strategi
could
combin
recent
publish
algorithm
predict
crrna
effici
streamlin
crrna
valid
process
wessel
et
al
crrna
select
test
therapeut
need
evalu
offtarget
effect
experiment
use
whole
transcriptom
rna
sequenc
furthermor
demonstr
pacman
system
abl
inhibit
viral
sequenc
vitro
therapeut
use
requir
effect
vivo
deliveri
method
human
respiratori
tract
cell
final
pacman
need
valid
relev
preclin
model
ferret
rhesu
macaqu
primari
human
lungairway
organoid
model
test
antivir
efficaci
specif
huh
et
al
anim
model
also
provid
inform
relat
immunogen
issu
arisen
studi
mehta
merkel
step
includ
clinic
trial
like
take
year
pacman
abl
stem
current
rise
tide
case
relat
death
potenti
use
futur
viral
threat
biggest
barrier
deploy
pacman
clinic
develop
effect
safe
vivo
deliveri
method
sever
attract
deliveri
option
could
employ
vivo
express
pacman
compon
cognat
crrna
could
deliv
rna
form
within
chemic
polym
lipid
nanoparticl
lnp
hendel
et
al
mckinlay
et
al
sago
et
al
xu
et
al
dnabas
liposom
deliveri
strategi
lipitoid
recent
develop
hedg
platform
also
attract
handumrongkul
et
al
huang
et
al
anoth
strategi
would
deliv
ribonucleoprotein
complex
contain
protein
assembl
crrna
amirkhanov
stepanov
xu
et
al
work
success
use
engin
amphiphil
peptid
deliv
rna
complex
airway
epithelia
provid
promis
approach
deliv
pacman
complex
krishnamurthi
et
al
addit
recent
advanc
gene
therapi
deliveri
strategi
optim
cystic
fibrosi
deliv
mrna
plasmid
dna
selfassembl
peptidepoloxamin
nanoparticl
may
also
option
guan
et
al
anticip
one
abovement
strategi
potenti
administ
patient
healthi
popul
via
nebul
system
nasal
spray
antivir
strategi
sever
technic
limit
need
overcom
use
pacman
clinic
instanc
pacman
act
cellautonom
manner
mean
cell
express
crrna
directli
protect
target
virus
pacman
effect
patient
need
abl
suffici
express
certain
percentag
cell
rang
would
need
determin
experiment
addit
work
shown
sequenc
cleavag
effici
sensit
crrna
express
figur
abil
tune
level
cognat
crrna
cell
may
import
achiev
effici
viral
inhibit
anoth
consider
viral
genom
may
less
suscept
inhibit
due
secondari
structur
rna
genom
coat
protect
protein
address
highthroughput
screen
crrna
may
help
identifi
highli
effect
crrna
target
live
optim
test
limit
may
prove
surmount
barrier
overcom
pacman
strategi
use
therapeut
uniqu
benefit
tradit
vaccin
potenti
pancoronaviru
protect
use
offer
altern
complementari
approach
tradit
pharmaceut
vaccin
tradit
vaccin
reli
prime
immun
system
exposur
viral
protein
peptid
often
deriv
surfac
protein
exhibit
high
rate
mutat
increas
chanc
viral
evas
host
immun
respons
carrat
flahault
contrast
demonstr
genet
strategi
abl
target
highli
conserv
region
would
expect
make
much
less
like
viru
escap
inhibit
mutat
addit
abil
process
crrna
crrna
array
mean
multipl
crrna
target
differ
region
eg
figur
figur
could
deliv
simultan
konermann
et
al
reduc
chanc
viral
escap
advantag
demonstr
potenti
pancoronaviru
strategi
target
virus
circul
human
also
found
anim
reservoir
crrna
target
virus
test
valid
ever
infect
human
greatli
acceler
develop
countermeasur
futur
emerg
threat
summari
pacman
strategi
repres
potenti
power
new
approach
inhibit
viral
function
replic
envis
could
use
target
divers
array
circul
emerg
viral
threat
detail
method
provid
onlin
version
paper
includ
follow
author
thank
member
stanley
qi
lab
david
lewi
lab
facilit
experi
use
discuss
author
thank
research
gener
contribut
sequenc
data
gisaid
http
wwwgisaidorg
author
would
also
like
thank
dr
author
file
provision
patent
via
stanford
univers
relat
work
request
materi
direct
lead
contact
lei
qi
stanleyqi
stanfordedu
materi
reagent
made
avail
upon
instal
materi
transfer
agreement
mta
plasmid
also
deposit
addgen
http
wwwaddgeneorgstanleyqi
code
comput
analysi
deposit
github
http
cell
cultur
primari
cell
viral
strain
cell
cultur
cell
line
incub
c
co
human
embryon
kidney
cell
cell
atcc
cultur
fetal
bovin
serum
thermo
fisher
scientif
dmem
thermo
fisher
scientif
gener
titer
mneon
iav
mneon
iav
gener
insert
mneon
fluoresc
gene
segment
apuerto
strain
nichola
heaton
lab
duke
univers
previous
describ
viru
propag
chicken
egg
harvest
allanto
fluid
contain
viru
titer
use
mdck
plaqu
assay
frozen
aliquot
later
use
genom
sequenc
collect
complet
assembl
download
http
februari
coronavirina
complet
genom
sequenc
download
vipr
viru
pathogen
resourc
databas
februari
exclud
short
genom
collect
total
coronavirina
viru
genom
genom
sequenc
download
gisaid
global
initi
share
influenza
data
http
wwwgisaidorg
develop
full
comput
workflow
design
crrna
system
design
possibl
crrna
three
pathogen
rna
virus
sarscov
merscov
refer
genom
sarscov
merscov
along
genom
deriv
patient
first
align
mafft
use
theauto
flag
crrna
candid
identifi
use
slide
window
extract
nt
sequenc
perfect
ident
among
genom
annot
crrna
candid
number
mismatch
rel
sarscov
merscov
genom
well
gc
content
crrna
candid
select
perfectli
match
genom
mismatch
sarscov
merscov
sequenc
character
specif
crrna
ensur
crrna
target
sequenc
human
transcriptom
use
bowti
align
crrna
human
transcriptom
includ
noncod
rna
remov
crrna
map
human
transcriptom
fewer
mismatch
maxim
vertic
coverag
pool
crrna
target
maxim
set
coronavirina
virus
minim
set
crrna
slide
window
use
extract
uniqu
sequenc
coronavirina
genom
yield
uniqu
crrna
candid
hash
tabl
use
map
crrna
candid
number
coronavirina
genom
target
perfect
match
greedi
algorithm
use
identifi
minim
set
cover
crrna
iter
crrna
sort
descend
order
number
genom
target
crrna
target
genom
ad
minim
set
crrna
genom
target
remov
hash
tabl
valu
multipl
crrna
tie
target
genom
crrna
rank
length
quantiti
stretch
repeat
nucleotid
lowest
rank
crrna
ie
one
fewest
shortest
stretch
repeat
nucleotid
ad
set
minim
crrna
use
approach
set
crrna
identifi
abl
target
coronavirina
viru
genom
includ
phylogenet
tree
associ
annot
gener
interact
tree
life
itol
http
itolembld
paniav
crrna
pool
gener
use
iter
greedi
algorithm
describ
method
section
comput
predict
minim
number
crrna
pancoronaviru
target
unlik
iav
genom
compos
noncontigu
segment
comput
pipelin
adjust
extract
slide
window
segment
crrna
defin
target
given
strain
perfect
match
segment
strain
complet
genom
sequenc
align
sarscov
merscov
ncbi
refseq
sequenc
mafft
use
theauto
flag
align
visual
use
geneiou
prime
softwar
geneiou
http
www
geneiouscom
consensu
nucleotid
share
nongap
charact
given
posit
assign
posit
align
everi
posit
consensu
nucleotid
percent
conserv
posit
calcul
percentag
sequenc
match
consensu
posit
aid
interpret
result
plot
percentag
conserv
smooth
use
move
averag
window
size
bp
center
posit
posit
correspond
gap
charact
refer
sequenc
omit
crrna
plasmid
clone
use
standard
restrictionlig
clone
forward
revers
oligo
spacer
idt
anneal
insert
backbon
use
dna
ligas
neb
assembl
oligo
either
insert
phr
backbon
obtain
modifi
addgen
respect
spacer
sequenc
crrna
found
tabl
clone
report
phrpgkscfv
digest
gel
purifi
pgk
promot
sfgfp
pcr
amplifi
gel
purifi
fragment
synthes
integr
dna
technolog
idt
last
pgk
sfgfp
fragment
insert
linear
vector
use
infus
clone
takara
bio
day
one
confluent
dish
corn
cell
seed
three
dish
corn
day
cell
confluent
time
transfect
dish
mg
phr
vector
contain
construct
interest
mg
mg
addgen
mix
ml
optimem
reduc
serum
media
gibco
ml
miru
reagent
incub
room
temperatur
minut
transfect
complex
solut
distribut
evenli
cultur
dropwis
day
lentivirus
harvest
supernat
steril
syring
filter
polyvinyliden
fluorid
filter
millipor
cell
lentiviru
precipit
solut
alstem
ad
precipit
per
manufactur
protocol
one
well
plate
corn
cell
confluenc
transduc
precipit
lentiviru
day
growth
cell
supernat
contain
viru
remov
cell
expand
cell
sort
mcherri
cell
use
soni
cell
sorter
figur
day
cell
stabli
express
hereaft
refer
seed
densiti
cell
per
well
plate
day
cell
transduc
pool
crrna
target
specif
region
tabl
day
cell
switch
fresh
medium
puromycin
ugml
twentyfour
hour
puromycin
select
cell
transfect
crrna
challeng
report
plasmid
report
lentiviru
twentyfour
hour
transfect
hour
transduct
cell
test
use
flow
cytometri
beckmancoult
cytoflex
quantit
realtim
pcr
biorad
realtim
system
statist
analys
done
use
twosid
test
unequ
varianc
excel
calcul
p
valu
figur
day
wildtyp
cell
cell
plate
plate
corn
day
cell
transfect
two
pool
crrna
target
two
report
nontarget
crrna
along
respect
report
equimolar
ratio
use
miru
reagent
ml
optimem
reduc
serum
media
mg
crrna
pool
mg
report
ml
miru
per
well
wildtyp
cell
transfect
either
crrna
pool
report
plasmid
compens
control
gfp
express
measur
day
flow
cytometri
beckmancoult
cytoflex
instrument
statist
analys
done
use
twosid
test
unequ
varianc
excel
calcul
p
valu
transduct
report
plasmid
day
lentix
cell
takara
bio
seed
mm
dish
mm
dish
follow
day
lentix
cell
transfect
mg
report
mg
mg
addgen
ml
optimem
reduc
serum
media
gibco
ml
miru
reagent
wildtyp
cell
also
seed
plate
day
cell
transfect
pool
target
crrna
nontarget
guid
ml
optimem
reduc
serum
media
mg
crrna
pool
ml
miru
per
well
day
lentivirus
harvest
supernat
steril
syring
filter
polyvinyliden
fluorid
filter
precipit
lentiviru
precipit
solut
resuspend
ml
dmem
media
media
cell
replac
either
fresh
media
compens
control
ml
viruscontain
media
follow
dilut
experiment
condit
undilut
dilut
dilut
dilut
day
media
cell
replac
ml
fresh
dmem
day
cell
measur
flow
cytometri
assess
gfp
knockdown
statist
analys
done
use
twosid
test
unequ
varianc
excel
calcul
p
valu
iav
challeng
experi
cell
plate
two
mm
dish
follow
day
cell
transfect
mg
pool
crrna
target
iav
genom
nontarget
control
tabl
ml
optimem
reduc
serum
media
ml
miru
reagent
approxim
hour
transfect
cell
dissoci
replat
plate
densiti
cellswel
incub
overnight
flow
cytometri
perform
excess
cell
quantifi
transfect
effici
cell
challeng
overnight
mneongreen
express
apuerto
moi
uninfect
cell
includ
neg
control
independ
twotail
test
use
calcul
p
valu
statist
figur
quantit
realtim
pcr
quantit
realtim
pcr
perform
quantifi
rna
abund
sampl
total
rna
isol
use
rneasi
plu
mini
kit
qiagen
cat
follow
cdna
synthesi
use
iscript
cdna
synthesi
kit
biorad
cat
qrtpcr
primer
order
integr
dna
technolog
idt
quantit
realtim
pcr
perform
use
primepcr
assay
sybr
green
master
mix
biorad
run
biorad
realtim
system
touch
thermal
cycler
accord
manufactur
instruct
cq
valu
use
quantifi
rna
abund
rel
abund
fragment
normal
gapdh
intern
control
calcul
rel
mrna
abund
express
treatment
rel
gapdh
normal
set
averag
valu
report
sampl
microscopi
iav
experi
perform
use
keyenc
microscop
equip
gfp
texa
red
filter
obtain
imag
object
len
flow
cytometri
cell
express
transfect
crrna
challeng
mneon
viru
wash
pb
treat
trypsin
edta
fix
paraformaldehyd
pb
minut
cell
wash
fac
buffer
pb
bsa
edta
bd
accuri
plu
flow
cytomet
use
collect
raw
data
raw
data
process
cytobank
bd
softwar
challeng
experi
data
collect
use
bd
accuri
cytomet
data
analyz
use
flowjo
refer
key
resourc
tabl
katoh
standley
langmead
et
al
letun
bork
cell
may
pleas
cite
articl
press
abbott
et
al
develop
crispr
antivir
strategi
combat
influenza
cell
http
quantif
repress
effici
flow
cytometri
figur
valu
repres
mean
fluoresc
signal
gfp
posit
cell
statist
analys
perform
use
twosid
test
unequ
varianc
excel
calcul
p
valu
tabl
quantit
rtpcr
qrtpcr
quantif
rna
abund
qrtpcr
figur
rel
rna
express
fragment
normal
gapdh
intern
control
calcul
rel
mrna
abund
rel
rna
express
treatment
normal
set
averag
valu
report
sampl
statist
analys
perform
use
twosid
test
unequ
varianc
excel
calcul
p
valu
tabl
low
crrna
high
high
crrna
low
low
crrna
low
panel
show
percentag
quantifi
mneon
cell
two
infect
condit
moi
dot
repres
percentag
singl
randomli
chosen
microscopi
field
view
fov
blue
nontarget
nt
crrna
red
target
crrna
n
infect
well
per
condit
fov
cell
count
per
condit
b
flow
cytometri
screen
pool
target
iav
genom
segment
percentag
mneon
cell
segment
use
target
crrna
pool
compar
nt
crrna
moi
left
right
shown
n
infect
well
pool
togeth
singl
flow
cytometri
tube
condit
c
microscopi
quantif
crrna
pool
target
iav
moi
n
randomli
chosen
fov
cell
count
per
condit
biolog
n
figur
bioinformat
pipelin
predict
minimum
set
pancoronaviru
crrna
design
relat
figur
bioinformat
pipelin
analyz
predict
pancoronaviru
target
crrna
number
crrna
step
workflow
denot
parenthes
articl
